Cymbalta, which is used to treat Fibromyalgia and ME/CFS patients, is one of 20 drugs currently under investigation by the FDA. It is under investigation due to the possibility of urinary retention. To better inform the … [Read more...] about Cymbalta Under FDA Investigation
Cymbalta
FDA Approves Cymbalta for Fibromyalgia
The FDA has approved Cymbalta (duloxetine) as a prescription drug for treatment of Fibromyalgia pain. This is according to a release today made by Eli Lilly & Co., the maker of the drug. Cymbalta is only the second … [Read more...] about FDA Approves Cymbalta for Fibromyalgia
Cymbalta Study For Treatment of Fibromyalgia
A study was conducted to see what an effect Cymbalta (Duloxetine) and other antidepressants had on the treatment of Fibromyalgia. Duloxetine is a newer selective serotonin and norepinephrine reuptake inhibitor (SNRI) on the … [Read more...] about Cymbalta Study For Treatment of Fibromyalgia
Fibromyalgia Treatment Drug Approved by FDA Expected
The first FDA Fibromyalgia treatment drug is to be approved by 2008. The pharmaceutical industry is racing to try and gain approval since prescription drugs for Fibromyalgia is an untapped market. The report appeared in … [Read more...] about Fibromyalgia Treatment Drug Approved by FDA Expected
Cymbalta – Another Medication With Significant Health Risks
Cymbalta is an antidepressant manufactured by Eli Lilly & Company - the same company that produced Prozac. Cymbalta was approved by the FDA in late summer of 2004. Not too long after the release of Cymbalta, side … [Read more...] about Cymbalta – Another Medication With Significant Health Risks